Processa Pharmaceuticals Files 8-K Amendment
Ticker: PCSA · Form: 8-K/A · Filed: Sep 16, 2025 · CIK: 1533743
| Field | Detail |
|---|---|
| Company | Processa Pharmaceuticals, Inc. (PCSA) |
| Form Type | 8-K/A |
| Filed Date | Sep 16, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, disclosure
TL;DR
Processa Pharma filed an 8-K amendment on Sept 16, updating corporate docs and financials from Sept 11.
AI Summary
Processa Pharmaceuticals, Inc. filed an amendment (No. 1) to its Form 8-K on September 16, 2025, reporting events that occurred on September 11, 2025. The filing primarily concerns amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, formerly known as Heatwurx, Inc., is incorporated in Delaware and headquartered in Vero Beach, Florida.
Why It Matters
This amendment provides updated information regarding Processa Pharmaceuticals' corporate governance and financial reporting, which is crucial for investors to understand the company's current status and any changes in its structure or operations.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily concerns administrative and disclosure items, not a significant new event or financial distress.
Key Players & Entities
- Processa Pharmaceuticals, Inc. (company) — Registrant
- Heatwurx, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of Incorporation
- Vero Beach, FL (location) — Business Address
- September 11, 2025 (date) — Date of earliest event reported
- September 16, 2025 (date) — Filing Date
FAQ
What is the primary purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report and concerns amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 11, 2025.
What is the filing date of this amendment?
This amendment was filed as of September 16, 2025.
What was Processa Pharmaceuticals, Inc. formerly known as?
Processa Pharmaceuticals, Inc. was formerly known as Heatwurx, Inc.
In which state is Processa Pharmaceuticals, Inc. incorporated?
Processa Pharmaceuticals, Inc. is incorporated in Delaware.
Filing Stats: 943 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2025-09-16 10:19:47
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share PCSA Nasdaq Ca
Filing Documents
- form8-ka.htm (8-K/A) — 54KB
- ex3-1.htm (EX-3.1) — 24KB
- 0001493152-25-013648.txt ( ) — 251KB
- pcsa-20250911.xsd (EX-101.SCH) — 3KB
- pcsa-20250911_lab.xml (EX-101.LAB) — 33KB
- pcsa-20250911_pre.xml (EX-101.PRE) — 22KB
- form8-ka_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROCESSA PHARMACEUTICALS, INC. Date: September 16, 2025 By: /s/ Russell Skibsted Russell Skibsted Chief Financial Officer